Pediatric & Childhood Cancer News Articles

Adult Survivors of Childhood Cancer May Face Late-Onset Memory Impairment

June 2, 2023

Adult survivors of childhood cancer have an elevated risk of late-onset memory impairment, a study suggests.

CIRS-G Reveals Accelerated Aging, Early Death in Childhood Cancer Survivors

June 1, 2023

Researchers have used a geriatric rating scale to show that childhood cancer survivors experience accelerated aging and have a higher risk of premature death than the general population.

Few Cancer Drugs Are Approved Within 10 Years of Entering Trials

May 24, 2023

The probability that a cancer drug would receive FDA approval within 10 years of entering trials was 10.4%, researchers found.

Childhood Cancer Survivors Have Higher Risk of Late Surgical Interventions

May 23, 2023

Childhood cancer survivors have a higher risk of requiring surgical interventions up to 35 years after diagnosis, a large study suggests.

MIS-C Increases Risk of Hospitalization, Death in Cancer Patients With COVID-19

May 17, 2023

Pediatric cancer patients who develop MIS-C after COVID-19 have a worse clinical course than patients without MIS-C, a study suggests.

Adding Blinatumomab to Chemotherapy May Improve Survival in Infant ALL

April 27, 2023

The combination of blinatumomab and chemotherapy appears safe and effective in infants with KMT2A-rearranged ALL, according to researchers.

Four or More CT Scans in Childhood Linked to Increased Risk of Cancer

April 25, 2023

Exposure to 4 or more CT scans before the age of 18 is associated with an increased risk of intracranial tumors, leukemia, and lymphoma, a study suggests.

Extreme Poverty Tied to Increased Risk of Relapse for Children With ALL

April 25, 2023

Among children receiving maintenance treatment for acute lymphoblastic leukemia, those living in extreme poverty have an increased risk of relapse, a study suggests.

Pediatric Cancer Survivors Have 4-Fold Higher Risk of Death 40 Years After Diagnosis

April 13, 2023

From 15 to 40 years after diagnosis, pediatric cancer survivors have a roughly 4-fold higher risk of death than the general population, a study suggests.

CAR T-Cell Therapy Demonstrates Activity in Pediatric Neuroblastoma

April 7, 2023

CAR T-cell therapy targeting GD2 appears safe and active in children with heavily pretreated neuroblastoma.

ART and Pediatric Cancer: Risk May Vary by Method Used, Cancer Type

March 31, 2023

Research has suggested that ART may increase the risk of pediatric cancers, but studies have shown conflicting results, and questions remain.

Tafinlar Plus Mekinist Approved for Pediatric BRAF V600E Low-Grade Glioma

March 20, 2023

The FDA approved the combination to treat pediatric patients 1 year of age and older who have low-grade glioma with a BRAF V600E mutation and require systemic therapy.

Cost of Cancer for AYAs Exceeds $250,000 Over a Lifetime

March 9, 2023

In the US, AYAs with cancer face high economic and human costs throughout their lifetime.

Texas-Mexico Border Residence Linked to Worse Survival in Children With ALL

February 28, 2023

Living along the Texas-Mexico border is associated with worse survival in children diagnosed with acute lymphoblastic leukemia.

Responses Fleeting With CAR-T Reinfusion in Children, AYAs With B-ALL

February 27, 2023

Reinfusion with the CAR T-cell therapy tisagenlecleucel does not produce durable remissions in children and AYAs with B-ALL, a study suggests.

Maternal Infection Linked to Increased Risk of Childhood Leukemia

February 24, 2023

Maternal infections, especially genital and urinary tract infections, during pregnancy are associated with an increased risk of childhood leukemia in offspring, a study suggests.

Social Vulnerability Tied to Worse Pediatric Head and Neck Cancer Outcomes

February 24, 2023

Increasing social vulnerability is associated with significant decreases in surveillance and survival time among pediatric patients with head and neck cancers.